Experience with hair testing in the clinical biochemistry laboratory of Ca' Granda Niguarda Hospital, Milan, Italy

被引:10
|
作者
Cassani, M
DaRe, N
Giuliani, L
Sesana, F
机构
关键词
hair analysis; GC/MS confirmation; opiates; cocaine;
D O I
10.1016/S0379-0738(96)02044-0
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
In our laboratory, analysis of human hair for drugs of abuse detection was first performed in 1980. In the last 10 years we have processed about 2000 subjects/year ('living subjects' only). In the last 3 years we have also introduced hair analysis of cocaine: at first only in clinical applications, but for the last 2 years this analysis is now routine. Our application of hair analysis includes: clinical toxicology, medico-legal and administrative agencies. Requests come for example from several Committees for Driving Licenses, Addiction Treatment Centers and Legal Authorities. Hair samples are currently collected from the occipital area at the back of the head, which appears to show less variability in hair growth rate. At present we perform hair analysis using highly sensitive radioimmunoassay screening methods for the detection of parent drug and/or metabolites. All positive cases of cocaine and opiates abuse are confirmed by gas chromatography-mass spectrometry in electron impact or chemical ionization mode. Positive cases for opiates are also analysed using a specific morphine radioimmunoassay kit. Data show that, when the opiates/morphine ratio is higher than 6, we are dealing with consumption of codeine and/or dihydrocodeine. In our routine work last year there were 177 (263 samples) positive opiates subjects out of 2244 patients; positive cocaine subjects were 290 (362 samples) out of 2001 patients. Guidelines for hair analysis in Lombardia have been established based on the experience of our laboratory. Furthermore it will be possible to apply a unique protocol for all Committees for Driving Licenses, involving hair testing in addition to urine assay. (C) 1997 Elsevier Science Ireland Ltd.
引用
下载
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [41] Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems
    Lanzoni, Monica
    Olivero, Barbara
    Artoni, Andrea
    Marconi, Maurizio
    Raspollini, Elisabetta
    Castaldi, Silvana
    BLOOD TRANSFUSION, 2018, 16 (03) : 253 - 261
  • [42] Diagnosis and follow up of Moroccan patients with homocystinuria: Experience of biochemistry laboratory of children's hospital of Rabat
    Dahri, S.
    Talbaoui, H.
    Vianey-Saban, C.
    Chabraoui, L.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 28 - 28
  • [43] IMPLEMENTATION OF SIGMA METRICS FOR EVALUATION OF ANALYTICAL QUALITY IN CLINICAL BIOCHEMISTRY LABORATORY OF A TERTIARY CARE HOSPITAL
    Choudhury, Jayati Roy
    Banerjee, Sayari
    Chakraborty, Indranil
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (21): : 2539 - 2542
  • [44] The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Point of Care pH Testing
    Nichols, James H.
    POINT OF CARE, 2007, 6 (04): : 247 - 252
  • [45] The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Point of Care Coagulation Testing
    Zucker, Marcia L.
    POINT OF CARE, 2007, 6 (04): : 223 - 226
  • [46] CLINICAL VIRUS ISOLATES IN A HOSPITAL DIAGNOSTIC LABORATORY - 6 YEAR EXPERIENCE
    DACSO, CC
    HARMON, MW
    GREENBERG, SB
    COUCH, RB
    KNIGHT, V
    CLINICAL RESEARCH, 1978, 26 (06): : A768 - A768
  • [47] Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
    Bali, Deeksha S.
    Goldstein, Jennifer L.
    Rehder, Catherine
    Kazi, Zoheb B.
    Berrier, Kathryn L.
    Dai, Jian
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 : 76 - 79
  • [48] Non-Invasive Prenatal Testing: Laboratory Clinical Experience: 20000 Clinical Samples
    Savarese, G.
    De Falco, L.
    Savarese, P.
    Ruggiero, R.
    D'Amore, L.
    Suero, T.
    Circelli, L.
    D'Angelo, R.
    Ramiro, C.
    Pisano, I.
    Di Carlo, A.
    Evangelista, E.
    Furino, G.
    Bruno, M.
    Vicedomini, C.
    Fico, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1197 - 1197
  • [49] National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure
    Tang, W. H. Wilson
    Francis, Gary S.
    Morrow, David A.
    Newby, L. Kristin
    Cannon, Christopher P.
    Jesse, Robert L.
    Storrow, Alan B.
    Christenson, Robert H.
    Christenson, Robert H.
    Apple, Fred S.
    Cannon, Christopher P.
    Francis, Gary S.
    Jesse, Robert L.
    Morrow, David A.
    Newby, L. Kristin
    Ravkilde, Jan
    Storrow, Alan B.
    Tang, W. H. Wilson
    Wu, Alan H. B.
    CIRCULATION, 2007, 116 (05) : E99 - E109
  • [50] National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure
    Tang, W. H. Wilson
    Francis, Gary S.
    Morrow, David A.
    Newby, L. Kristin
    Cannon, Christopher P.
    Jesse, Robert L.
    Storrow, Alan B.
    Christenson, Robert H.
    CLINICAL BIOCHEMISTRY, 2008, 41 (4-5) : 210 - 221